Young Li
Stock Analyst at Jefferies
(0.89)
# 4,453
Out of 5,182 analysts
8
Total ratings
60%
Success rate
-12.3%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $26.71 | -19.49% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $101.26 | +43.20% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $7.17 | +25.52% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $63.09 | +82.28% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.30 | -3.85% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $23.40 | +156.41% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $15.29 | +200.85% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $26.71
Upside: -19.49%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $101.26
Upside: +43.20%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $7.17
Upside: +25.52%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $63.09
Upside: +82.28%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.30
Upside: -3.85%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $23.40
Upside: +156.41%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $15.29
Upside: +200.85%